BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 18404164)

  • 1. The ERBB3 receptor in cancer and cancer gene therapy.
    Sithanandam G; Anderson LM
    Cancer Gene Ther; 2008 Jul; 15(7):413-48. PubMed ID: 18404164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of erbB3 receptor to overcome resistance in cancer treatment.
    Ma J; Lyu H; Huang J; Liu B
    Mol Cancer; 2014 May; 13():105. PubMed ID: 24886126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of erbB3 receptors in cancer therapeutic resistance.
    Lee Y; Ma J; Lyu H; Huang J; Kim A; Liu B
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):190-8. PubMed ID: 24449784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells.
    Grøvdal LM; Kim J; Holst MR; Knudsen SL; Grandal MV; van Deurs B
    Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation.
    Shi F; Telesco SE; Liu Y; Radhakrishnan R; Lemmon MA
    Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7692-7. PubMed ID: 20351256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells.
    Ratchford AM; Baker OJ; Camden JM; Rikka S; Petris MJ; Seye CI; Erb L; Weisman GA
    J Biol Chem; 2010 Mar; 285(10):7545-55. PubMed ID: 20064929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.
    Frolov A; Schuller K; Tzeng CW; Cannon EE; Ku BC; Howard JH; Vickers SM; Heslin MJ; Buchsbaum DJ; Arnoletti JP
    Cancer Biol Ther; 2007 Apr; 6(4):548-54. PubMed ID: 17457047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
    Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
    Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
    Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
    Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.
    Stern DF
    J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):215-23. PubMed ID: 18454306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia.
    Black LE; Longo JF; Carroll SL
    Am J Pathol; 2019 Oct; 189(10):1898-1912. PubMed ID: 31351986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic ERBB3 mutations in human cancers.
    Jaiswal BS; Kljavin NM; Stawiski EW; Chan E; Parikh C; Durinck S; Chaudhuri S; Pujara K; Guillory J; Edgar KA; Janakiraman V; Scholz RP; Bowman KK; Lorenzo M; Li H; Wu J; Yuan W; Peters BA; Kan Z; Stinson J; Mak M; Modrusan Z; Eigenbrot C; Firestein R; Stern HM; Rajalingam K; Schaefer G; Merchant MA; Sliwkowski MX; de Sauvage FJ; Seshagiri S
    Cancer Cell; 2013 May; 23(5):603-17. PubMed ID: 23680147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.
    Liles JS; Arnoletti JP; Tzeng CW; Howard JH; Kossenkov AV; Kulesza P; Heslin MJ; Frolov A
    Cancer Biol Ther; 2010 Sep; 10(6):555-63. PubMed ID: 20647770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heregulin-ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells.
    Yarar D; Lahdenranta J; Kubasek W; Nielsen UB; MacBeath G
    Mol Cancer Ther; 2015 Sep; 14(9):2072-80. PubMed ID: 26116360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.
    Zhang Y; Linn D; Liu Z; Melamed J; Tavora F; Young CY; Burger AM; Hamburger AW
    Mol Cancer Ther; 2008 Oct; 7(10):3176-86. PubMed ID: 18852121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells.
    Ueno Y; Sakurai H; Tsunoda S; Choo MK; Matsuo M; Koizumi K; Saiki I
    Int J Cancer; 2008 Jul; 123(2):340-347. PubMed ID: 18398842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
    Ishizawar RC; Miyake T; Parsons SJ
    Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging.
    Macdonald-Obermann JL; Adak S; Landgraf R; Piwnica-Worms D; Pike LJ
    J Biol Chem; 2013 Oct; 288(42):30773-30784. PubMed ID: 24014028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
    Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
    Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.